Nuvaxovid™ is the only protein-based, non-mRNA COVID-19 vaccine available in the U.S. for the 2025-2026 vaccination season "With today's approval, we will work with our partner Sanofi to provide ...

There may soon be another COVID-19 vaccine on the market in the U.S. Novavax announced Monday that it has submitted a request to the Food and Drug Administration for emergency use authorization for ...

The FDA announced limits on who can receive this year’s COVID vaccines. But can you still get a shot if you don’t meet the ...

A version of this article first appeared in CNBC's Healthy Returns newsletter, which brings the latest health-care news straight to your inbox. Subscribe here to receive future editions. Novavax can ...

The FDA’s top vaccine regulator outlines proposed changes to the vaccine evaluation process in an internal memo.

FILE - A vial of the Phase 3 Novavax coronavirus vaccine is seen ready for use in the trial at St. George's University hospital in London, Oct. 7, 2020. The Novavax COVID-19 vaccine that could soon ...

Shares of two major Covid-19 vaccine makers declined Monday after a Food and Drug Administration official [claimed the shots]( ...

This year’s updated COVID-19 vaccines have been approved by the U.S. Food and Drug Administration for adults 65 and older and younger people with certain medical conditions that put them at a higher ...

The Food and Drug Administration gave the greenlight to updated COVID-19 shots Wednesday, maintaining unrestricted access for all Americans 65 and older while significantly limiting eligibility for ...